Shock wave induces chronic renal lesion through activation of the nuclear factor kappa B signaling pathway

World Journal of Urology

Volumn 28, Issue 5, 2010, Pages 657-662

  Li, Xiang ^a   Xue, Yuquan ^a   He, Dalin ^a   Chen, Xingfa ^a   Zhang, Linlin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Extracorporeal shock wave lithotripsy; Inflammation; Renal fibrosis

Indexed keywords

COLLAGEN TYPE 3; CREATININE; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ANIMAL MODEL; ARTICLE; BLOOD; DRUG ANTAGONISM; FIBROSIS; INJURY; KIDNEY; LITHOTRIPSY; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; COLLAGEN TYPE III; CREATININE; FIBROSIS; KIDNEY; LITHOTRIPSY; MALE; MODELS, ANIMAL; NF-KAPPA B; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; THIOCARBAMATES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77957169828     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0515-9     Document Type: Article

References (14)

1. Evan AP, McAteer JA, Bailey MR et al (2002) Kidney damage and renal functional changes are minimized by waveform control that suppresses cavitation in shock wave lithotripsy. J Urol 168: 1556-1562.
2. Krambeck AE, Gettman MT, Rohlinger AL et al (2006) Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of follow up. J Urol 175(5): 1742-1747.
3. Munver R, Delvecchio F, Kuo RL et al (2002) In vivo assessment of free radical activity during shock wave lithotripsy using a microdialysis system: the renoprotective action of allopurinol. J Urol 167(1): 327-334.
4. Eliseev RA, Zuscik MJ, Schwarz EM et al (2005) Increased radiation-induced apoptosis of Saos2 cells via inhibition of NF-kappaB: a role for c-Jun N-terminal kinase. J Cell Biochem 96(6): 1262-1273.
5. Davis ME, Davis ME, Grumbach IM et al (2004) Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J Biol Chem 279(1): 163-168.
6. Suetsugu H, Iimuro Y, Uehara T et al (2005) Nuclear factor-kappaB inactivation in the rat liver ameliorates short term total warm ischemia/reperfusion injury. Gut 54(6): 835-842.
7. Li X, He D, Zhang L et al (2007) Pyrrolidine dithiocarbamate attenuate shock wave induced MDCK cells injury via inhibiting nuclear factor-kappa B activation. Urol Res 35(4): 193-199.
8. Schreck R, Meier B, Männel DN et al (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175: 1181-1194.
9. Guijarro C, Egido J (2001) Transcription factor-κB (NFκB) and renal disease. Kidney Int 59: 415-424.
10. Li Q, Engelhardt JF (2006) Interleukin-1beta induction of NFkappa B is partially regulated by H2O2-mediated activation of NFkappa B-inducing kinase. J Biol Chem 281(15): 1495-1505.
11. Wen Y, Yang S, Liu R et al (2004) Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res 1008(2): 147-154.
12. Cohen TD, Durrani AF, Brown SA et al (1998) Lipid peroxidation induced by shockwave lithotripsy. J Endourol 12(3): 229-232.
13. Durante W, Liao L, Reyna SV et al (2001) Transforming growth factor-beta 1 stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation 103: 1121-1127.
14. Laiho M, Saksela O, Keski-Oja J (1987) Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J Biol Chem 262: 17467-17474.